$650 Million Upfront + Up to $135M Contingent Payments Exclusive Financial Advisor Acquisition of AZSTARYS® from Corium Therapeutics Pending
UNDISCLOSED Lead Financial Advisor Infusion Specialty Therapies Business Unit Divested to ESTEVE March 2026